Cargando…
Inflammatory demyelinating polyneuropathy versus leptomeningeal disease following Ipilimumab
BACKGROUND: Ipilimumab is an FDA-approved anti-CTLA-4 monoclonal antibody used in treatment of metastatic melanoma. We present an unusual neurological complication of Ipilimumab therapy and the diagnostic dilemma it caused. CASE PRESENTATION: A 42 year old male with Stage IV metastatic melanoma deve...
Autores principales: | Cafuir, Lorraine, Lawson, David, Desai, Nilesh, Kesner, Vita, Voloschin, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791192/ https://www.ncbi.nlm.nih.gov/pubmed/29382383 http://dx.doi.org/10.1186/s40425-018-0318-x |
Ejemplares similares
-
Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018) -
How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast
por: Desai, Urvi
Publicado: (2023) -
Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
por: Sung, Woo Kyung, et al.
Publicado: (2015) -
Inflammatory demyelinating polyneuropathy after total hip arthroplasty
por: Hess, Shane R., et al.
Publicado: (2018) -
Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy
por: Min, Young Gi, et al.
Publicado: (2020)